Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The report indicates that the new tobacco business is progressing steadily, with guidance for double-digit growth in 2026 [2] - The company expects revenue growth of 4% in 2026, followed by 3% in 2027 and 2028, with net profit growth of 6%, 7%, and 5% respectively [8] Financial Summary - Total revenue (in million GBP) is projected as follows: 2024: 25,867; 2025: 25,610; 2026E: 26,634; 2027E: 27,433; 2028E: 28,256, with a year-on-year change of -5%, -1%, 4%, 3%, and 3% respectively [5] - Gross profit is expected to increase from 2,406 in 2024 to 11,906 in 2028 [5] - Net profit is projected to rise from 3,068 in 2024 to 9,246 in 2028, with significant growth in 2025 [5] - The PE ratio is forecasted to decrease from 43.03 in 2024 to 14.28 in 2028, indicating improved valuation [5] Market Performance - The stock has a 52-week price range of $36.35 to $63.22, with a current market capitalization of $132 billion [5] - The report highlights a recovery in the vaping business, with the VUSE brand returning to growth in the second half of 2025 [8] - The company is also focusing on new product launches in the heated tobacco segment, with expectations for improved market performance [8]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The report indicates that the new tobacco business is progressing steadily, with guidance for double-digit growth in 2026 [2] - The company expects revenue growth of 4% in 2026, followed by 3% in both 2027 and 2028, with net profit growth of 6%, 7%, and 5% respectively during the same period [8] Financial Summary - Total revenue (in million GBP) is projected as follows: 2024: 25,867; 2025: 25,610; 2026E: 26,634; 2027E: 27,433; 2028E: 28,256, with a year-on-year change of -5%, -1%, +4%, +3%, and +3% respectively [5] - Gross profit is expected to increase from 2,406 million GBP in 2024 to 11,906 million GBP in 2028 [5] - Net profit is forecasted to rise from 3,068 million GBP in 2024 to 9,246 million GBP in 2028, with year-on-year changes of -121%, +153%, +6%, +7%, and +5% respectively [5] - The price-to-earnings (PE) ratio is projected to decrease from 43.03 in 2024 to 14.28 in 2028 [5] Market Performance - The company's stock price has ranged between 36.35 and 63.22 USD over the past 52 weeks, with a current market capitalization of 132,002 million USD [5]

Summary of British American Tobacco (NYSE:BTI) Conference Call - December 09, 2025 Company Overview - **Company**: British American Tobacco (BAT) - **Date**: December 09, 2025 - **Key Speakers**: Victoria Buxton (Group Head of Investor Relations), Tadeu Marocco (Chief Executive), Javed Iqbal (Interim Chief Financial Officer) Key Industry Insights - **Industry**: Global nicotine industry, particularly focusing on combustibles, modern oral products, and vapor categories - **Market Dynamics**: The industry is experiencing a transformation with adult smokers increasingly switching to new categories, particularly modern oral products and vapor Core Points and Arguments 1. **Revenue and Profit Growth**: BAT expects around 2% revenue and adjusted operating profit growth for the full year 2025, with positive momentum in the U.S. business driven by combustibles and VLO Plus performance [2][3] 2. **New Category Growth**: Anticipated acceleration in new category revenue growth to double digits in the second half of 2025, with mid-single-digit growth expected for the full year [2][3] 3. **Modern Oral Products**: Modern Oral is the fastest-growing category, with VLO gaining volume share up 590 basis points to 31.8% in key markets. The category is positioned as a lower-risk alternative to traditional cigarettes [4][5] 4. **FDA Support**: The FDA is recognized for its role in tobacco harm reduction, with a commitment to provide science-based information about nicotine products, which is expected to facilitate consumer transitions to reduced harm products [5][6] 5. **Velo Plus Performance**: Velo Plus has achieved significant growth, reaching a 21.9% volume share in October, up from 6.9% prior to its launch, and is driving triple-digit revenue growth in the U.S. [6][7] 6. **Heated Products**: The heated products segment is undergoing a transitional phase, with a new product, glo Halo, launched in Japan, aimed at capturing the premium segment [9][10] 7. **Vapor Category Recovery**: Vuse has regained volume and revenue growth in the U.S. after 18 months of decline, with a 50.4% value share, supported by increased federal enforcement against illicit products [11][12] 8. **Combustibles Performance**: The U.S. combustibles business is expected to deliver revenue and profit growth for the first time since 2022, with a decline in industry volume improving compared to previous years [15][16] 9. **Regulatory Challenges**: Significant regulatory headwinds in markets like Bangladesh and Australia are expected to impact overall revenue growth, with illicit trade accounting for over 85% of nicotine usage in these regions [16][17] 10. **Financial Discipline**: BAT maintains a strong cash generation profile, with operating cash conversion expected to exceed 95% in 2025 and a commitment to deleveraging [17][18] Additional Important Insights - **Market Exit Strategy**: BAT plans to exit underperforming markets like Mozambique and Cuba, which will impact organic growth figures [28][37] - **Investment in Innovation**: Continued investment in premium products and innovation is prioritized, with a focus on maintaining competitive advantages in the market [30][31] - **Future Guidance**: For 2026, BAT expects to achieve revenue growth at the lower end of its mid-term algorithm, with a focus on sustainable financial delivery and transformation [19][35] Conclusion - BAT is optimistic about its growth trajectory, particularly in the U.S. market, and is committed to delivering sustainable shareholder value through dividends and share buybacks while navigating regulatory challenges and market dynamics [18][47]